Kornitzer Capital Management Inc Harrow Health, Inc. Transaction History
Kornitzer Capital Management Inc
- $4.73 Billion
- Q2 2025
A detailed history of Kornitzer Capital Management Inc transactions in Harrow Health, Inc. stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 30,000 shares of HROW stock, worth $1.04 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$1.04 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
187Shares Held
22.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$138 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$74.8 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$65.9 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$65.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$33.3 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $943M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...